EverSource Wealth Advisors LLC Acquires 346 Shares of Humana Inc. (NYSE:HUM)

EverSource Wealth Advisors LLC lifted its holdings in Humana Inc. (NYSE:HUMGet Rating) by 100.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 689 shares of the insurance provider’s stock after buying an additional 346 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Humana were worth $300,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in HUM. HighTower Advisors LLC increased its position in Humana by 7.2% in the fourth quarter. HighTower Advisors LLC now owns 6,586 shares of the insurance provider’s stock worth $3,051,000 after purchasing an additional 442 shares during the period. Rafferty Asset Management LLC increased its position in Humana by 5.4% in the fourth quarter. Rafferty Asset Management LLC now owns 4,320 shares of the insurance provider’s stock worth $2,004,000 after purchasing an additional 223 shares during the period. Covestor Ltd acquired a new stake in Humana in the fourth quarter worth about $59,000. Prudential PLC acquired a new stake in Humana in the fourth quarter worth about $1,485,000. Finally, MAI Capital Management acquired a new stake in Humana in the fourth quarter worth about $211,000. 93.50% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Truist Financial lifted their price objective on Humana from $490.00 to $550.00 and gave the stock a “hold” rating in a research report on Thursday, July 14th. Credit Suisse Group set a $548.00 target price on Humana in a research report on Tuesday, July 19th. Morgan Stanley boosted their target price on Humana from $453.00 to $494.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 2nd. Oppenheimer boosted their target price on Humana from $510.00 to $520.00 and gave the stock an “outperform” rating in a research report on Thursday, July 28th. Finally, StockNews.com lowered Humana from a “strong-buy” rating to a “buy” rating in a research report on Friday, July 29th. Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $512.39.

Humana Trading Up 8.4 %

NYSE:HUM opened at $497.24 on Friday. The stock has a market capitalization of $62.93 billion, a PE ratio of 20.30, a price-to-earnings-growth ratio of 1.41 and a beta of 0.77. The business’s 50-day simple moving average is $485.48 and its 200-day simple moving average is $458.34. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.53 and a quick ratio of 1.53. Humana Inc. has a fifty-two week low of $351.20 and a fifty-two week high of $504.99.

Humana (NYSE:HUMGet Rating) last released its earnings results on Wednesday, July 27th. The insurance provider reported $8.67 EPS for the quarter, beating the consensus estimate of $7.67 by $1.00. The firm had revenue of $23.66 billion for the quarter, compared to analysts’ expectations of $23.44 billion. Humana had a return on equity of 18.42% and a net margin of 3.52%. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.89 EPS. Sell-side analysts expect that Humana Inc. will post 24.85 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, September 30th will be paid a $0.7875 dividend. This represents a $3.15 annualized dividend and a yield of 0.63%. The ex-dividend date is Thursday, September 29th. Humana’s payout ratio is 12.86%.

Humana Company Profile

(Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.